Discovery of TRV130, a G protein biased agonist of the μ-opioid receptor, for the treatment of acute severe pain

被引：0
|
作者：
Crombie, Aimee [1 ]
Chen, Xiao-Tao [1 ]
Pitis, Philip [1 ]
Liu, Guodong [1 ]
Yuan, Catherine [1 ]
Gotchev, Dimitar [4 ]
Yamashita, Dennis [3 ]
Violin, Jonathan [2 ]
机构：
[1] Trevena Inc, Chem, King Of Prussia, PA USA
[2] Trevena Inc, Biol, King Of Prussia, PA USA
[3] GSK, Discovery Partnerships Acad, Boston, PA USA
[4] Teva Pharmaceut, Chem, W Chester, PA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 249卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
34
引用
收藏
页数：2
相关论文
共 50 条
  • [41] μ-Opioid receptor ligand Treatment of moderate-to-severe acute pain
    Cole, P.
    DRUGS OF THE FUTURE, 2016, 41 (06) : 347 - 351
  • [42] The δ-opioid receptor positive allosteric modulator BMS 986187 is a G-protein-biased allosteric agonist
    Stanczyk, M. Alexander
    Livingston, Kathryn E.
    Chang, Louise
    Weinberg, Zara Y.
    Puthenveedu, Manojkumar A.
    Traynor, John R.
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (11) : 1649 - 1663
  • [43] A novel G protein-biased agonist at the m opioid receptor induces substantial receptor desensitization through G protein-coupled receptor kinase
    Groom, Sam
    Blum, Nina
    Conibear, Alexandra
    Hill, Rob
    Li, Yangmei
    Toll, Lawrence
    Kliewer, Andrea
    Schulz, Stefan
    Henderson, Graeme
    Kelly, Eamonn
    Bailey, Chris
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (02) : 450 - 450
  • [44] "Compound 1": An apparent G-protein-biased μ-opioid receptor agonist that induces receptor desensitization through GRK
    Groom, Sam
    Li, Yangmei
    Henderson, Graeme
    Kelly, Eamonn
    Bailey, Chris
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (11) : 2559 - 2561
  • [45] How Oliceridine (TRV-130) Binds and Stabilizes a μ-Opioid Receptor Conformational State That Selectively Triggers G Protein Signaling Pathways
    Schneider, Sebastian
    Provasi, Davide
    Filizola, Marta
    BIOCHEMISTRY, 2016, 55 (46) : 6456 - 6466
  • [46] A First-in-Human Clinical Study With TRV734, an Orally Bioavailable G-Protein-Biased Ligand at the μ-Opioid Receptor
    James, Ian E.
    Skobieranda, Franck
    Soergel, David G.
    Ramos, Kimberly A.
    Ruff, Dennis
    Fossler, Michael J.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (02): : 256 - 266
  • [47] Rapid reduction in pain intensity with oliceridine (TRV130), a novel μ receptor G protein Pathway Selective modulator (μ-GPS), vs. Morphine: an analysis of two phase 2 randomized clinical trials
    Viscusi, E.
    Minkowitz, H.
    Webster, L.
    Soergel, D.
    Burt, D.
    Subach, R.
    Skobieranda, F.
    JOURNAL OF PAIN, 2016, 17 (04): : S82 - S83
  • [48] 6′-Guanidinonaltrindole (6′-GNTI) Is a G Protein-biased κ-Opioid Receptor Agonist That Inhibits Arrestin Recruitment
    Rives, Marie-Laure
    Rossillo, Mary
    Liu-Chen, Lee-Yuan
    Javitch, Jonathan A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (32) : 27050 - 27054
  • [49] Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers
    Soergel, David G.
    Subach, Ruth Ann
    Burnham, Nancy
    Lark, Michael W.
    James, Ian E.
    Sadler, Brian M.
    Skobieranda, Franck
    Violin, Jonathan D.
    Webster, Lynn R.
    PAIN, 2014, 155 (09) : 1829 - 1835
  • [50] Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ1 Receptor Antagonist Clinical Candidate for the Treatment of Pain
    Garcia, Monica
    Virgili, Marina
    Alonso, Monica
    Alegret, Carles
    Farran, Joan
    Fernandez, Begona
    Bordas, Magda
    Pascual, Rosalia
    Burgueno, Javier
    Vidal-Torres, Alba
    Fernandez de Henestrosa, Antonio R.
    Ayet, Eva
    Merlos, Manuel
    Miguel Vela, Jose
    Plata-Salaman, Carlos R.
    Almansa, Carmen
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (24) : 15508 - 15526
12345